Health Care Worker In New Jersey Tests Negative For Ebola, State Says | Fox News

Health Care Sector Update for 01/21/2015: ADXS,NVIV,OCLS –

She was admitted to the hospital as a precaution after vomiting and having a fever on United Airlines flight 45 Monday, which traveled from Brussels, Belgium, to Newark, N.J., officials said. Ebola is spread through direct contact with the bodily fluids of an infected person who is showing symptoms. Officials from Hackensack said the patient was monitored overnight for gastrointestinal illness, and doctors determined she did not have Ebola. ADVERTISEMENT ADVERTISEMENT According to the statement, the individual will be monitored for 21 days, the maximum incubation period for Ebola, when signs of the virus can appear and be transmitted to other people. Per New Jerseys policy, the patient will be tracked for signs of Ebola during this time, as are all individuals who are returning from the three West African countries hardest hit by Ebola: Liberia, Sierra Leone and Guinea. Newark Liberty is one of five airports allowed to receive flights carrying people coming from West Africa.

8 after a short-seller posted a negative Seeking Alpha article today, writing trial data for the company’s ADXS-HPV lead drug candidate overstates its ability to fight tumors. Blogger Richard Pearson dismisses many of the factors helping lift ADXS shares more than 60% since November, arguing the company’s stock is soon poised for a steep drop. In particular, he directs much of his scorn at Mission IR and its “Dream Team Group,” which he accuses of “dumping” favorable articles onto stock research websites as part of a broader effort to push ADXS’ share price higher. “This is simply another heavily promoted, retail-driven microcap stock being traded by technical day traders for the moment,” Pearson said, later adding it and similar stocks lacking broad institutional support are often subject to “wild swings on [investor] sentiment.” here is what you need alex simring ADXS shares were down over 22% at $9.14 each, erasing nearly all of its gains this month after the company Jan. 7 announced a collaboration pact with the GOG Foundation to work on Phase III testing of ADXS-HPV in patients with cervical cancer. The stock has traded within a 52-week range of $2.46 to $13.74 a share, rising more than 83% over the past year prior to today’s drop. In other sector news, (+) NVIV, Reports improved motor, sensory, bowel and bladder function and no serious adverse events during the first three months following installation of its neuro-spinal scaffold in patients with acute spinal cord injury. (-) OCLS, Prices public offering of 6.25 mln shares at $1 each, a 14% discount to Tuesday’s closing price. Pockets $6.3 mln in gross proceeds, which will be used to expand the company’s direct sales force and for new research and development. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc. Copyright (C) 2014
Health Care Sector Update for 01/21/2015: ADXS,NVIV,OCLS –


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s